This is an audio transcript of the FT News Briefing podcast episode: ‘Spain’s migrant crisis exposes serious challenges for ...

Merck did not begin in a laboratory, but in a neighborhood pharmacy that still opens every day to fill prescriptions for local residents... Some subscribers prefer to save their log-in information so ...

Merck & Co., Inc. ( MRK) Discusses HIV Program Updates and Phase III Data from International AIDS Conference August 3, 2026 8:00 AM EDT ...

Merck's second quarter was marked by continued sales growth, primarily driven by the strength of its oncology portfolio and ...

There’s no right answer, but rather a host of possibilities.

Following in the footsteps of Gilead Sciences, Merck & Co. has signed voluntary licensing agreements to enable access to its investigational HIV PrEP pill alimatravir. The New Jersey pharma is ...

Merck & Co. won US regulatory approval of a pill that rivals powerful injections for cutting dangerous cholesterol levels, betting the easier-to-take medicine will find more success with high-risk ...

Merck said on Thursday the U.S. FDA has approved its cholesterol pill, the first of its kind to receive the health regulator’s nod, bolstering the drugmaker’s efforts to diversify beyond its ...

July 24 (Reuters) - Merck (MRK.N), opens new tab said on Friday it signed seven voluntary licensing agreements with generic drug manufacturers to make and sell lower-cost versions of its ‌experimental ...

Merck won U.S. Food and Drug Administration approval on Thursday for Lipfendra (enlicitide), making it the first oral PCSK9 inhibitor cleared by the agency to lower LDL cholesterol in adults with ...

Since reaching the market a decade ago, PCSK9 inhibitors have not lived up to their lofty expectations. While drugs such as Amgen’s Repatha and Regeneron and Sanofi’s Praluent have proven more ...